Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
New technology allows scientists to dive into the inner world of cells in everything from cancers to mummies. Learn more at lab’s open house on July 10.
Several drugs in development for pancreatic cancer dissolve the dense tissue that surrounds and protects the tumors, but new research shows why some may not work.